Drug-Related Side Effects and Adverse Reactions Clinical Trial
Official title:
Investigation of Genetic Variations on Patients With Adverse Events While on Direct Oral Anticoagulants (DOACs)
The purpose of this study is to see if the participant's genetic profile and clinical factors (age, drug dose, etc.) affect drug outcomes (i.e. serious bleeding) that the participant may have experienced since taking the drug (direct oral anticoagulant) for preventing blood clots from forming in the blood vessels.
Genes can have variants or mutations that can increase the participant's risk for bleeding when receiving a direct oral anticoagulant (DOACs). The investigators will be studying participants on DOACs who have had bleeding and also participants who are on DOACs who did not have bleeding (control group). The goal of the study is to determine the accuracy of Cipherome's Drug Safety Score (DSS) in it's ability to predict adverse drug reactions (ADRs). A DSS score ranges from 0 to 1, with scores less than 0.3 correlated with a higher risk of ADRs and scores more than 0.7 correlated with a lower risk of ADRs. The participant's DSS score will be compared with the actual clinical outcome using a statistical test to determine the accuracy of the DSS. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT03258151 -
Association of Genetic Polymorphisms With Docetaxel-based Chemotherapy Toxicities in Chinese Solid Tumor Patients
|
||
| Recruiting |
NCT05202964 -
Compliance and Tolerance to Oral AntiBiotherapy in Osteoarticular Infections (OTABIO)
|
||
| Completed |
NCT04597593 -
Association Between Genetic Variant Scores and DOACs (DARES2)
|
||
| Recruiting |
NCT05096338 -
Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate Cancer
|
||
| Recruiting |
NCT05078190 -
Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Breast Cancer
|
||
| Completed |
NCT02457039 -
Acupuncture Prevents Chemobrain in Breast Cancer Patients
|
N/A | |
| Completed |
NCT02779530 -
CYP4A11 and CYP4F2 Gene Variants as Makers of Cardiovascular Adverse Events of Non-steroidal Anti-inflammatory Drugs
|
Phase 4 | |
| Recruiting |
NCT03047863 -
Therapeutic Effect of EGF Cream for Cutaneous Adverse Event of EGFR Inhibitors
|
N/A | |
| Recruiting |
NCT03051880 -
Preventive Effect of EGF Cream for Cutaneous Adverse Event of EGFR Inhibitors
|
N/A | |
| Completed |
NCT02482025 -
The Secure Messaging for Medication Reconciliation Tool (SMMRT) Trial
|
N/A | |
| Not yet recruiting |
NCT03147157 -
The Effect of Human Leukocyte Antigen Macthing on Guiding Tacrolimus Regimen After Liver Transplantation
|
N/A | |
| Recruiting |
NCT03156348 -
Impact of Clinical Pharmacist on Adverse Drug Events in Older Adults
|
N/A | |
| Recruiting |
NCT03501108 -
Discontinuation of Long-term Medications in Older People Entering Nursing Home Care
|
N/A | |
| Recruiting |
NCT06427317 -
Routinely Collected Clinical Data and Evaluation of Antimicrobial Target Attainment
|
||
| Completed |
NCT03227653 -
Neuropsychiatric Side Effects of Efavirenz in Children Living With HIV
|
||
| Completed |
NCT03177174 -
Different Chemotherapy Protocols Combined With Intensity Modulated Radiation Therapy in Patients With Locally Advanced Nasopharyngeal Carcinoma
|
N/A | |
| Recruiting |
NCT04077281 -
Improving Medication Prescribing-Related Outcomes for Vulnerable Elderly In Transitions
|
N/A | |
| Not yet recruiting |
NCT05247814 -
Individual Risk Profiles for Adverse Drug Reactions in Geriatric Patients
|
||
| Recruiting |
NCT03938597 -
Investigation of Serious Adverse Events Following Vaccination Against Yellow Fever: Emphasis on Genetic Basis and Biological Markers
|
||
| Recruiting |
NCT06291688 -
Applying Mobile Healthcare Education to Improve Cutaneous Self-care Capability
|
N/A |